Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2001
ANX7, a candidate tumor suppressor gene for prostate cancer
M Srivastava, L Bubendorf, V Srikantan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
A Zer, M-J Ahn, F Barlesi, et al.
The Journal of Biological Chemistry
|
November 24, 1999
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo
S K Lee, S L Anzick, J E Choi, et al.
ESMO Open
|
July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D König, S Savic Prince, S Hayoz, et al.
The New England Journal of Medicine
|
February 24, 2001
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, et al.
The Journal of Pathology
|
July 6, 2001
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
A Nocito, L Bubendorf, E M Tinner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 21, 2019
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
E Thunnissen, B I Lissenberg-Witte, M M van den Heuvel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
K M Kerr, U Dafni, K Schulze, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2001
ANX7, a candidate tumor suppressor gene for prostate cancer
M Srivastava, L Bubendorf, V Srikantan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
A Zer, M-J Ahn, F Barlesi, et al.
The Journal of Biological Chemistry
|
November 24, 1999
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo
S K Lee, S L Anzick, J E Choi, et al.
ESMO Open
|
July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D König, S Savic Prince, S Hayoz, et al.
The New England Journal of Medicine
|
February 24, 2001
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, et al.
The Journal of Pathology
|
July 6, 2001
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
A Nocito, L Bubendorf, E M Tinner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 21, 2019
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
E Thunnissen, B I Lissenberg-Witte, M M van den Heuvel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
K M Kerr, U Dafni, K Schulze, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
Page
of 9